142 related articles for article (PubMed ID: 26231324)
1. A Pilot Randomized Trial of Financial Incentives or Coaching to Lower Serum Phosphorus in Dialysis Patients.
Reese PP; Mgbako O; Mussell A; Potluri V; Yekta Z; Levsky S; Bellamy S; Parikh CR; Shults J; Glanz K; Feldman HI; Volpp K
J Ren Nutr; 2015 Nov; 25(6):510-7. PubMed ID: 26231324
[TBL] [Abstract][Full Text] [Related]
2. Effect of food additives on hyperphosphatemia among patients with end-stage renal disease: a randomized controlled trial.
Sullivan C; Sayre SS; Leon JB; Machekano R; Love TE; Porter D; Marbury M; Sehgal AR
JAMA; 2009 Feb; 301(6):629-35. PubMed ID: 19211470
[TBL] [Abstract][Full Text] [Related]
3. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study.
Block GA; Hulbert-Shearon TE; Levin NW; Port FK
Am J Kidney Dis; 1998 Apr; 31(4):607-17. PubMed ID: 9531176
[TBL] [Abstract][Full Text] [Related]
4. Self-Motivation Is Associated With Phosphorus Control in End-Stage Renal Disease.
Umeukeje EM; Merighi JR; Browne T; Victoroff JN; Umanath K; Lewis JB; Ikizler TA; Wallston KA; Cavanaugh K
J Ren Nutr; 2015 Sep; 25(5):433-9. PubMed ID: 25912398
[TBL] [Abstract][Full Text] [Related]
5. Dose-response and efficacy of ferric citrate to treat hyperphosphatemia in hemodialysis patients: a short-term randomized trial.
Dwyer JP; Sika M; Schulman G; Chang IJ; Anger M; Smith M; Kaplan M; Zeig S; Koury MJ; Blumenthal SS; Lewis JB;
Am J Kidney Dis; 2013 May; 61(5):759-66. PubMed ID: 23369827
[TBL] [Abstract][Full Text] [Related]
6. Results of a pilot program to improve phosphorus outcomes in hemodialysis patients.
Mayne TJ; Benner D; Ricketts K; Burgess M; Wilson S; Poole L; Smyth M; Colson C; Krishnan M
J Ren Nutr; 2012 Sep; 22(5):472-9. PubMed ID: 22056148
[TBL] [Abstract][Full Text] [Related]
7. Understanding the associations between modifying factors, individual health beliefs, and hemodialysis patients' adherence to a low-phosphorus diet.
Elliott JO; Ortman C; Almaani S; Lee YH; Jordan K
J Ren Nutr; 2015 Mar; 25(2):111-20. PubMed ID: 25282006
[TBL] [Abstract][Full Text] [Related]
8. RenaGel, a nonabsorbed calcium- and aluminum-free phosphate binder, lowers serum phosphorus and parathyroid hormone. The RenaGel Study Group.
Slatopolsky EA; Burke SK; Dillon MA
Kidney Int; 1999 Jan; 55(1):299-307. PubMed ID: 9893140
[TBL] [Abstract][Full Text] [Related]
9. Dietary intervention focused on phosphate intake in hemodialysis patients with hyperphosphoremia.
Lou LM; Caverni A; Gimeno JA; Moreno R; Pérez J; Alvarez R; Campos B; García M; Gutiérrez A; Bielsa S; Castilla J; Sanz A; Martin F;
Clin Nephrol; 2012 Jun; 77(6):476-83. PubMed ID: 22595390
[TBL] [Abstract][Full Text] [Related]
10. Phosphorus Counting Table for the control of serum phosphorus levels without phosphate binders in hemodialysis patients.
Bertonsello-Catto VR; Lucca LJ; da Costa JAC
Clin Nutr ESPEN; 2019 Aug; 32():153-157. PubMed ID: 31221281
[TBL] [Abstract][Full Text] [Related]
11. Dose-finding study of bixalomer in patients with chronic kidney disease on hemodialysis with hyperphosphatemia: a double-blind, randomized, placebo-controlled and sevelamer hydrochloride-controlled open-label, parallel group study.
Akizawa T; Origasa H; Kameoka C; Kaneko Y; Kanoh H
Ther Apher Dial; 2014 Jun; 18 Suppl 2():24-32. PubMed ID: 24975892
[TBL] [Abstract][Full Text] [Related]
12. Coaching patients On Achieving Cardiovascular Health (COACH): a multicenter randomized trial in patients with coronary heart disease.
Vale MJ; Jelinek MV; Best JD; Dart AM; Grigg LE; Hare DL; Ho BP; Newman RW; McNeil JJ;
Arch Intern Med; 2003 Dec 8-22; 163(22):2775-83. PubMed ID: 14662633
[TBL] [Abstract][Full Text] [Related]
13. Nicotinamide suppresses hyperphosphatemia in hemodialysis patients.
Takahashi Y; Tanaka A; Nakamura T; Fukuwatari T; Shibata K; Shimada N; Ebihara I; Koide H
Kidney Int; 2004 Mar; 65(3):1099-104. PubMed ID: 14871431
[TBL] [Abstract][Full Text] [Related]
14. Implementation and effectiveness of an intensive education program on phosphate control among hemodialysis patients: a non-randomized, single-arm, single-center trial.
Yin J; Yin J; Lian R; Li P; Zheng J
BMC Nephrol; 2021 Jul; 22(1):243. PubMed ID: 34210293
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of hypoalbuminemic hemodialysis patients with a modified regimen of oral essential amino acids.
Bronich L; Te T; Shetye K; Stewart T; Eustace JA
J Ren Nutr; 2001 Oct; 11(4):194-201. PubMed ID: 11679999
[TBL] [Abstract][Full Text] [Related]
16. Feasibility and Safety of Intradialysis Yoga and Education in Maintenance Hemodialysis Patients.
Birdee GS; Rothman RL; Sohl SJ; Wertenbaker D; Wheeler A; Bossart C; Balasire O; Ikizler TA
J Ren Nutr; 2015 Sep; 25(5):445-53. PubMed ID: 25869658
[TBL] [Abstract][Full Text] [Related]
17. [Nutritional knowledge and perception on dialysis: influence on adhesion and transgression; initial study].
de las Heras Mayoral MT; Martínez Rincón C
Nutr Hosp; 2014 Sep; 31(3):1366-75. PubMed ID: 25726235
[TBL] [Abstract][Full Text] [Related]
18. Hemodialysis Self-management Intervention Randomized Trial (HED-SMART): A Practical Low-Intensity Intervention to Improve Adherence and Clinical Markers in Patients Receiving Hemodialysis.
Griva K; Nandakumar M; Ng JH; Lam KFY; McBain H; Newman SP
Am J Kidney Dis; 2018 Mar; 71(3):371-381. PubMed ID: 29198641
[TBL] [Abstract][Full Text] [Related]
19. Viewing an educational video can improve phosphorus control in patients on hemodialysis: a pilot study.
Baldwin DM
Nephrol Nurs J; 2013; 40(5):437-42; quiz 443. PubMed ID: 24308110
[TBL] [Abstract][Full Text] [Related]
20. Effect of a dietitian-managed bone algorithm on serum phosphorus level in maintenance hemodialysis patients.
Blair D; Byham-Gray L; Sweet SJ; Denmark R; Parrott JS; Lewis E; McCaffrey S; Thomson S
J Ren Nutr; 2013 Mar; 23(2):98-105.e2. PubMed ID: 22800689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
